Indian SSI Mantra robot shows safe, promising outcomes in 157 uro-oncology cases


 A new competitor has entered the robotic surgery market with the "Made in India" SSI Mantra™ system, designed to break the monopoly of expensive western platforms. A recent study evaluating the system's performance in over 150 uro-oncology procedures found it to be safe and effective, with patients experiencing only minor complications and good functional recovery. 

The system features a modular design with an open console and up to five arms, offering ergonomic benefits and lower costs compared to traditional platforms. While further comparative trials are needed, this early data suggests that the SSI Mantra could significantly improve access to advanced minimally invasive surgery in developing nations where cost has traditionally been a barrier.


Read the original article at: https://www.sciencedirect.com/science/article/pii/S2214388224001255


Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.

Comments

Popular posts from this blog

Generative AI Will Transform Healthcare, But Only If We Get the Governance Right

AI in healthcare Insights: 20th November - 26th November' 2025

Clinical AI & MedTech Insights: January 22 - January 28